Category:
Active Pharmaceutical Ingredients
CAS NO:
926927-61-9
Standard:
In-house Standards,
Oncology Ovarian Cancer
Motolimod (VTX-2337) is a synthetic small-molecule TLR8 agonist designed for immunotherapy. Its core mechanism involves direct activation of Toll-like receptor 8 to enhance innate immune responses in hematologic malignancies. Molecular Formula: C15H19N3O4; CAS No: 1386790-76-2.
Strict adherence to clinical protocols is required due to potential cytokine release syndrome. Storage must maintain controlled room temperature (20-25°C) in dry, light-resistant conditions to preserve chemical stability during manufacturing.